Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

490 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes.
De Marco G, Helliwell P, McGonagle D, Emery P, Coates LC, Hensor EMA, Marzo-Ortega H. De Marco G, et al. BMC Musculoskelet Disord. 2017 Jul 18;18(1):303. doi: 10.1186/s12891-017-1659-1. BMC Musculoskelet Disord. 2017. PMID: 28720139 Free PMC article. Clinical Trial.
GRAPPA 2019 Project Report.
Goel N, Coates LC, De Marco G, Eder L, FitzGerald O, Helliwell PS, Leung YY, Maksymowych WP, Mease PJ, Østergaard M, O'Sullivan D, Poddubnyy D, Ritchlin CT, Gladman DD. Goel N, et al. Among authors: de marco g. J Rheumatol Suppl. 2020 Jun;96:53-57. doi: 10.3899/jrheum.200129. J Rheumatol Suppl. 2020. PMID: 32482770 Free article.
Systematic literature review of non-topical treatments for early, untreated (systemic therapy naïve) psoriatic disease: a GRAPPA initiative.
De Marco G, Berekméri A, Coates LC, Dubash S, Emmel J, Gladman DD, Lubrano E, McGonagle DG, Mahmood F, Marchesoni A, Mason L, Ogdie A, Wittmann M, Helliwell PS, Marzo-Ortega H. De Marco G, et al. Rheumatol Adv Pract. 2020 Jul 11;4(2):rkaa032. doi: 10.1093/rap/rkaa032. eCollection 2020. Rheumatol Adv Pract. 2020. PMID: 33542971 Free PMC article. Review.
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19.
Alunno A, Najm A, Machado PM, Bertheussen H, Burmester GR, Carubbi F, De Marco G, Giacomelli R, Hermine O, Isaacs JD, Koné-Paut I, Magro-Checa C, McInnes I, Meroni PL, Quartuccio L, Ramanan AV, Ramos-Casals M, Rodríguez Carrio J, Schulze-Koops H, Stamm TA, Tas SW, Terrier B, McGonagle DG, Mariette X. Alunno A, et al. Among authors: de marco g. Ann Rheum Dis. 2021 Jun;80(6):698-706. doi: 10.1136/annrheumdis-2020-219724. Epub 2021 Feb 5. Ann Rheum Dis. 2021. PMID: 33547062 Free PMC article.
490 results